542 / 1481
Spencer et al.
Cancer
2014; 120:3994-4002.
• Median follow-up 37 months.
• Locoregional recurrence at 2 years:
•
Pts with omitted contralateral high node level II 19.2%
•
Pts with omitted contralateral high node level II and retropharyngeal lymph
nodes 19%.
•
No regional recurrence in the omitted contralateral high node level II.
•
No regional recurrence in the omitted contralateral retropharyngeal
lymph nodes.
Target volume reduction (2)